The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort
Open accessPublished version of a preprint
Abstract
The novel respiratory disease COVID-19 produces varying symptoms, with fever, cough, and shortness of breath being common. In older adults, we found that pre-existing dementia is a major risk factor (OR = 3.07, 95% CI: 1.71 to 5.50) for COVID-19 hospitalization in the UK Biobank (UKB). In another UK study of 16,749 patients hospitalized for COVID-19, dementia was among the common comorbidities and was associated with higher mortality. Additionally, impaired consciousness, including delirium, is common in severe cases. The ApoE e4 genotype is associated with both dementia and delirium, with the e4e4 (homozygous) genotype associated with high risk of dementia. We therefore aimed to test associations between ApoE e4 alleles and COVID-19 severity, using the UKB data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, individuals with the ApoE3 allele may be more susceptible to severe forms of COVID-19 disease [183].”
From Cognitive decline following acute viral infections: literature review and projections for post-COVID-19 (2022) · cites this paper as [183]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The UK Biobank resource with deep phenotyping and genomic data
Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., O’Connell, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0579-z · Cited by 8,876
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481
Mao, L., Wang, M., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., Miao, X., Hu, Y., et al. (2020) · SSRN Electronic Journal · doi:10.1101/2020.02.22.20026500 · Cited by 909
Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2
Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W. (2020) · doi:10.1101/2020.01.26.919985 · Cited by 860
Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort
Atkins, J. L., Masoli, J. A. H., Delgado, J., Pilling, L. C., Kuo, C., Kuchel, G. A., & Melzer, D. R. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa183 · Cited by 497
Self-citationDocherty, A., Harrison, E., Green, C. A., et al. (2020) · medRxiv · doi:10.1101/2020.04.23.20076042 · Cited by 416
Pilling, L. C., Tamosauskaite, J., Jones, G., Wood, A. R., Jones, L., Kuo, C.-L., Kuchel, G. A., Ferrucci, L., & Melzer, D. (2019) · BMJ · doi:10.1136/bmj.k5222 · Cited by 198
Self-citationTudorache, I. F., Trusca, V. G., & Gafencu, A. V. (2017) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2017.05.003 · Cited by 186
Armstrong, J., Rudkin, J., Allen, N. E., Crook, D. W., Wilson, D. J., Wyllie, D. H., & O’Connell, A. M. (2020) · Microbial Genomics · doi:10.1099/mgen.0.000397 · Cited by 129
Cited by
Sorted by citations
Items 101–200 of 386
ApoE4 associated with severe COVID-19 outcomes via downregulation of ACE2 and imbalanced RAS pathway
Chen, F., Chen, Y., Ke, Q., Wang, Y., Gong, Z., Chen, X., Cai, Y., Li, S., Sun, Y., Peng, X., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03945-7 · Cited by 48
Programmed ageing: decline of stem cell renewal, immunosenescence, and Alzheimer's disease
Lathe, R., & Clair, D. S. (2023) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12959 · Cited by 37
COVID-19 severity is predicted by earlier evidence of accelerated agingPreprint
Kuo, C., Pilling, L. C., Atkins, J. L., Masoli, J. A. H., Delgado, J., Tignanelli, C. J., Kuchel, G. A., Melzer, D. R., Beckman, K. B., & Levine, M. E. (2020) · medRxiv · doi:10.1101/2020.07.10.20147777 · Cited by 33
Self-citationCOVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
Baazaoui, N., & Iqbal, K. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220105 · Cited by 35
The ApoE Locus and COVID-19: Are We Going Where We Have Been?
Finch, C. E., & Kulminski, A. M. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa200 · Cited by 31
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?
Krey, L., Huber, M. K., Höglinger, G. U., & Wegner, F. (2021) · Brain Sciences · doi:10.3390/brainsci11121654 · Cited by 31
Villa, C., Rivellini, E., Lavitrano, M., & Combi, R. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12010029 · Cited by 34
COVID-19 Usurps Host Regulatory Networks
Curran, C. S., Rivera, D. R. R., & Kopp, J. B. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01278 · Cited by 31
Coronavirus infection: An immunologists' perspective
Sanctis, J. B. D., García, A. H., Moreno, D., & Hajdúch, M. (2021) · Scandinavian Journal of Immunology · doi:10.1111/sji.13043 · Cited by 27
Clerbaux, L., Albertini, M. C., Amigó, N., Beronius, A., Bezemer, G. F. G., Coecke, S., Daskalopoulos, E. P., del Giudice, G., Greco, D., Grenga, L., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154464 · Cited by 30
A catalog of associations between rare coding variants and COVID-19 outcomesPreprint
Kosmicki, J. A., Horowitz, J. E., Banerjee, N., Lanche, R., Marcketta, A., Maxwell, E. K., Bai, X., Sun, D., Backman, J., Sharma, D., et al. (2020) · medRxiv · doi:10.1101/2020.10.28.20221804 · Cited by 28
Dcruz, M. M., & Banerjee, D. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.603231 · Cited by 27
de Erausquin, G. A., Snyder, H. M., Brugha, T. S., Seshadri, S. S., Carrillo, M. C., Sagar, R., Huang, Y., Newton, C. R. J. C., Tartaglia, M. C., Teunissen, C. E., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12348 · Cited by 27
Li, W., Sun, L., Yue, L., & Xiao, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1120495 · Cited by 30
The bidirectional interaction of COVID-19 infections and lipoproteins
Feingold, K. R. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101751 · Cited by 26
Is precision medicine relevant in the age of COVID-19?
Zhou, A., Sabatello, M., Eyal, G., Lee, S. S., Rowe, J. W., Stiles, D. F., Swanson, A., & Appelbaum, P. S. (2021) · Genetics in Medicine · doi:10.1038/s41436-020-01088-4 · Cited by 26
Meier, I. B., Teixeira, C. V. L., Tarnanas, I., Mirza, F., & Rajendran, L. (2021) · Brain Communications · doi:10.1093/braincomms/fcab012 · Cited by 26
Tavares-Júnior, J. W. L., Oliveira, D. N., da Silva, J. B. S., Feitosa, W. L. Q., Sousa, A. V. M., Cunha, L. C. V., Gaspar, S. D. B., Gomes, C. M. P., de Oliveira, L. L. B., Moreira-Nunes, C. A., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.947583 · Cited by 29
Update on human genetic susceptibility to COVID-19: susceptibility to virus and response
Colona, V. L., Vasiliou, V., Watt, J. L., Novelli, G., & Reichardt, J. K. V. (2021) · Human Genomics · doi:10.1186/s40246-021-00356-x · Cited by 25
Cooper, O., Hallett, P. J., & Ole Isacson, A. (2022) · FEBS Journal · doi:10.1111/febs.16638 · Cited by 26
Daramola, O. J., Nyasulu, P. S., Mashamba-Thompson, T. P., Moser, T., Broomhead, S. C., Hamid, A., Naidoo, J., Whati, L., Kotze, M. J., Stroetmann, K. A., et al. (2021) · Informatics · doi:10.3390/informatics8040063 · Cited by 24
Filipska, K., Biercewicz, M., Wiśniewski, A., Jabłońska, R., Królikowska, A., Główczewska-Siedlecka, E., Kędziora–Kornatowska, K., & Ślusarz, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194532 · Cited by 24
Care for dementia patients and caregivers amid COVID-19 pandemic
Paplikar, A., Rajagopalan, J., & Alladi, S. (2022) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2022.100040 · Cited by 24
Apolipoprotein E4 Allele in Subjects with COVID-19
Hubacek, J. A., Dlouhá, L., Dušek, L., Májek, O., & Adámková, V. (2021) · Gerontology · doi:10.1159/000516200 · Cited by 24
Magnesium treatment on methylation changes of transmembrane serine protease 2 (TMPRSS2)
Fan, L., Zhu, X., Zheng, Y., Zhang, W., Seidner, D. L., Ness, R. M., Murff, H. J., Yu, C., Huang, X., Shrubsole, M. J., et al. (2021) · Nutrition · doi:10.1016/j.nut.2021.111340 · Cited by 23
Human brain organoids to explore SARS‐CoV‐2‐induced effects on the central nervous system
Ostermann, P. N., & Schaal, H. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2430 · Cited by 23
Raha, A. A., Ghaffari, S. D., Henderson, J. W., Chakraborty, S., Allinson, K. S. J., Friedland, R. P., Holland, A. J., Zaman, S. H., Mukaetova-Ladinska, E. B., & Raha‐Chowdhury, R. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.653591 · Cited by 21
Association of Apolipoprotein e polymorphism with SARS-CoV-2 infection
Al-Jaf, S. M. A., Niranji, S. S., Ali, H. N., & Mohammed, O. A. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.105043 · Cited by 22
Markiewicz-Gospodarek, A., Górska, A., Markiewicz, R., Chilimoniuk, Z., Czeczelewski, M., Baj, J., Maciejewski, R., & Masiak, J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19159573 · Cited by 23
Chen, G., Hukportie, D. N., Wan, Z., Li, F., & Wu, X. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac228 · Cited by 22
Molecular cross-talk between long COVID-19 and Alzheimer’s disease
Pszczołowska, M., Walczak, K., Miśków, W., Antosz, K., Batko, J., Karska, J., & Leszek, J. (2024) · GeroScience · doi:10.1007/s11357-024-01096-1 · Cited by 23
Host polymorphisms and COVID-19 infection
Delanghe, J., & Speeckaert, M. M. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2021.07.002 · Cited by 22
Mercury neurotoxicity in gold miners
Lopez, M. E. C., Augusto‐Oliveira, M., Lopes-Araújo, A., Santos-Sacramento, L., Monteiro, J. R. S., da Rocha, F. F., & Arrifano, G. D. P. (2022) · Advances in neurotoxicology · doi:10.1016/bs.ant.2022.04.003 · Cited by 20
Gemmati, D., Longo, G., Gallo, I., Silva, J. A., Secchiero, P., Zauli, G., Hanau, S., Passaro, A., Pellegatti, P., Pizzicotti, S., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1028081 · Cited by 21
Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia
Greenblatt, C. L., & Lathe, R. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231323 · Cited by 21
Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?
Sagris, Μ., Theofilis, P., Antonopoulos, A. S., Oikonomou, E. K., Tsioufis, K., & Tousoulis, D. (2022) · Biomedicines · doi:10.3390/biomedicines10020242 · Cited by 22
The Intersection between COVID-19, the Gene Family of ACE2 and Alzheimer’s Disease
Haghighi, M. M., Kakhki, E. G., Sato, C., Ghani, M., & Rogaeva, E. A. (2020) · Neuroscience Insights · doi:10.1177/2633105520975743 · Cited by 20
Sfera, A., Thomas, K. G., Andronescu, C. V., Jafri, N., Sfera, D. O., Sasannia, S., del Campo, C. M. Z.-M., & Maldonado, J. C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.904816 · Cited by 21
Saify, K., Alborz, M. S., & Saadat, M. (2021) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-020-00124-x · Cited by 20
Grudlewska‐Buda, K., Wiktorczyk-Kapischke, N., Wałecka-Zacharska, E., Kwiecińska-Piróg, J., Buszko, K., Leis, K., Juszczuk, K., Gospodarek-Komkowska, E., & Skowron, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091962 · Cited by 27
Analysis of Genetic Host Response Risk Factors in Severe COVID-19 PatientsPreprint
Taylor, K., Das, S., Pearson, M. W., Kozubek, J. A., Pawłowski, M., Jensen, C. E., Skowron, Z., Møller, G. L., Strivens, M. A., & Gardner, S. (2020) · medRxiv · doi:10.1101/2020.06.17.20134015 · Cited by 19
Haghani, A., Thorwald, M. A., Morgan, T. E., & Finch, C. E. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12230 · Cited by 21
Shared genetic architecture of COVID-19 and Alzheimer’s disease
Matveeva, N. A., Сергеевич, К. И., Baulina, N., Semina, E. V., Kakotkin, V. V., Агапов, М. А., Кулакова, О. Г., & Favorova, O. O. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1287322 · Cited by 20
Kuo, C., Pilling, L. C., Atkins, J. L., Fortinsky, R. H., Kuchel, G. A., & Melzer, D. R. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab184 · Cited by 19
Self-citationCommentary: APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort
Kasparian, K., Graykowski, D. R., & Cudaback, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01939 · Cited by 20
Liu, P., Wang, A., Schwab‐Reese, L. M., & Stratton, S. K. (2021) · Journal of Family Violence · doi:10.1007/s10896-021-00305-1 · Cited by 18
Immunopathogenesis and Immunogenetic Variants in COVID-19
Sagulkoo, P., Plaimas, K., Suratanee, A., Simão, A. N. C., Reiche, E. M. V., & Maes, M. H. J. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220519150821 · Cited by 16
Pomilio, A. B., Vitale, A. A., & Lazarowski, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666221003101548 · Cited by 18
COVID‐19 and the impact on Alzheimer's disease pathology
Furman, S., Green, K. N., & Lane, T. E. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15985 · Cited by 18
Amadoro, G., Latina, V., Stigliano, E., & Micera, A. (2023) · Cells · doi:10.3390/cells12222601 · Cited by 20
Poor Metabolic Health Increases COVID-19-Related Mortality in the UK Biobank Sample
Morys, F., & Dagher, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.652765 · Cited by 18
A Chinese host genetic study discovered IFNs and causality of laboratory traits on COVID-19 severity
Zhu, H., Zheng, F., Li, L., Jin, Y., Luo, Y., Li, Z., Zeng, J., Tang, L. F. P., Li, Z., Xia, N., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103186 · Cited by 18
Alzheimer’s Disease Patients in the Crosshairs of COVID-19
Perry, G. L. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-209004 · Cited by 18
Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entryPreprint
Yuan, Z., Pavel, M. A., Wang, H., & Hansen, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.13.250217 · Cited by 19
Chu, J., Benjenk, I., & Chen, J. (2021) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.09.020 · Cited by 17
Hypotheses and facts for genetic factors related to severe COVID-19
Kotsev, S. V., Miteva, D., Krayselska, S., Shopova, M., Pishmisheva, M., Stanilova, S. A., & Velikova, T. V. (2021) · World Journal of Virology · doi:10.5501/wjv.v10.i4.137 · Cited by 18
Begemann, M., Groß, O., Wincewicz, D., Hardeland, R., Gastaldi, V. D., Vieta, E., Weißenborn, K., Miskowiak, K. W., Moerer, O., & Ehrenreich, H. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00381-5 · Cited by 18
The nervous system during COVID ‐19: Caught in the crossfire
Natale, N. R., Lukens, J. R., & Petri, W. A. (2022) · Immunological Reviews · doi:10.1111/imr.13114 · Cited by 19
Frontera, J. A., Guekht, A. B., Allegri, R., Ashraf, M., Baykan, B. B., Crivelli, L., Easton, A., García‐Azorín, D., Helbok, R., Joshi, J., et al. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.120827 · Cited by 17
Cholesterol and COVID-19—therapeutic opportunities at the host/virus interface during cell entry
Grewal, T., Nguyen, M. K. L., & Buechler, C. (2024) · Life Science Alliance · doi:10.26508/lsa.202302453 · Cited by 17
Pre-existing conditions in Hispanics/Latinxs that are COVID-19 risk factors
Chang, T. S., Ding, Y., Freund, M. K., Johnson, R., Schwarz, T., Yabu, J. M., Hazlett, C. J., Chiang, J. N., Wulf, D. A., Antonio, A. L., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102188 · Cited by 17
John, A. A., Ali, K., Marsh, H. D., & Reddy, P. H. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101406 · Cited by 18
Potential protective effect against SARS-CoV-2 infection by APOE rs7412 polymorphism
Espinosa‐Salinas, I., Colmenarejo, G., Fernández-Díaz, C. M., de Cedrón, M. G., Martínez, J. A., Reglero, G., & de Molina, A. R. (2022) · Scientific Reports · doi:10.1038/s41598-022-10923-4 · Cited by 19
The Prevention and Management of COVID-19: Seeking a Practical and Timely Solution
Jindal, C., Kumar, S., Sharma, S., Choi, Y. M., & Efird, J. T. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17113986 · Cited by 16
Huang, Q.-M., Zhang, P.-D., Li, Z., Zhou, J.-M., Liu, D., Zhang, X.-R., Zhong, W.-F., Zhang, Y.-J., Shen, D., Liang, F., et al. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202102-171oc · Cited by 15
Delshad, M., Sanaei, M., Pourbagheri‐Sigaroodi, A., & Bashash, D. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109128 · Cited by 18
Recent insights into viral infections as a trigger and accelerator in alzheimer's disease
Vlieger, L. D., Vandenbroucke, R. E., & Hoecke, L. V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103340 · Cited by 16
Current topics of frailty in association with hypertension and other medical conditions
Toba, A., & Ishikawa, J. (2023) · Hypertension Research · doi:10.1038/s41440-023-01200-6 · Cited by 16
Societal considerations in host genome testing for COVID-19
Milne, R. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0861-y · Cited by 16
Clark, I. A. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2210 · Cited by 15
Perspectives and Challenges in the Fight Against COVID-19: The Role of Genetic Variability
Guilger‐Casagrande, M., de Barros, C. T., Antunes, V. A. N., de Araújo, D. R., & de Lima, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.598875 · Cited by 17
de Araújo, J. L. F., Menezes, D., Saraiva‐Duarte, J. M., Ferreira, L. D. L., Aguiar, R. S., & de Souza, R. P. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2283 · Cited by 19
Shoemark, D. K., Colenso, C. K., Toelzer, C., Gupta, K., Sessions, R. B., Davidson, A. D., Berger, I., Schaffitzel, C., SPENCER, J. M., & Mulholland, A. J. (2021) · Angewandte Chemie · doi:10.1002/ange.202015639 · Cited by 16
Zecevic, M., Kotur, N., Ristivojević, B., Gašić, V., Škodrić-Trifunović, V., Stjepanović, M., Stevanović, G., Lavadinović, L., Zukić, B., Pavlović, S., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.911010 · Cited by 16
Genetics of COVID ‐19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review
Tziastoudi, M., Cholevas, C., Stefanidis, I., & Theoharides, T. C. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51631 · Cited by 19
Liang, N., Harsch, B. A., Zhou, S., Borkowska, A. G., Shearer, G. C., Kaddurah‐Daouk, R., Newman, J. W. I., & Borkowski, K. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101265 · Cited by 15
Kakale, M. M. (2023) · Health and Technology · doi:10.1007/s12553-023-00803-w · Cited by 22
FYN, SARS-CoV-2, and IFITM3 in the neurobiology of Alzheimer's disease
Vavougios, G. D., Breza, M., Mavridis, T., & Krogfelt, K. A. (2021) · Brain Disorders · doi:10.1016/j.dscb.2021.100022 · Cited by 14
Neuroimaging Patterns in Patients with COVID-19-Associated Neurological Complications
Garg, R. K., Paliwal, V. K., Malhotra, H. S., & Sharma, P. K. (2021) · Neurology India · doi:10.4103/0028-3886.314531 · Cited by 14
Human genetic basis of severe or critical illness in COVID-19
Ji, X., Chen, B., Ze, B., & Zhou, W.-H. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.963239 · Cited by 14
Gonzalez‐Fernandez, E., & Huang, J. (2023) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-023-01286-y · Cited by 15
Saadat, M. (2020) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-020-00094-0 · Cited by 14
Resurreccion, W. K., Hulsizer, J., Shi, Z., Wei, J., Wang, C., Na, R., Zheng, S. L., Struve, C., Helfand, B. T., Khandekar, J. D., et al. (2021) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-1657 · Cited by 14
Protons to Patients: targeting endosomal Na+/H+ exchangers against COVID‐19 and other viral diseases
Prasad, H. (2021) · FEBS Journal · doi:10.1111/febs.16163 · Cited by 15
Dementia and COVID-19: A Case Report and Literature Review on Pain Management
Scuteri, D., Contrada, M., Tonin, P., Corasaniti, M. T., Nicotera, P., & Bagetta, G. (2022) · Pharmaceuticals · doi:10.3390/ph15020199 · Cited by 14
Tang, C., Fang, Z., Chu, D., Zhang, L., Tang, Y., Zhou, J., Fang, R., Ying, J., Wang, F., Zhou, Y., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.849994 · Cited by 14
Putative role of mitochondria in SARS-CoV-2 mediated brain dysfunctions: a prospect
Maurya, S. K., Baghel, M. S., Gaurav, G., Chaudhary, V., Kaushik, A. K., & Gautam, A. (2022) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2022.2108998 · Cited by 14
Targeted screening of genetic associations with COVID-19 susceptibility and severity
Li, P., Ke, Y., Shen, W., Shi, S., Wang, Y., Lin, K., Guo, X., Wang, C., Zhang, Y., & Zhao, Z. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1073880 · Cited by 15
Postcovid syndrome — polymorphism of disorders in a new coronavirus infection
Belyakov, N. А., Trofimova, T. N., Рассохин, В. В., Mg, R., & Vasiliev, B. B. (2022) · HIV Infection and Immunosuppressive Disorders · doi:10.22328/2077-9828-2021-13-4-7-20 · Cited by 16
Martynowicz, H., Jodkowska, A., Poręba, R., Mazur, G. J., & Wieckiewicz, M. A. (2021) · Dental and Medical Problems · doi:10.17219/dmp/131795 · Cited by 16
Emerging neurotropic features of SARS-CoV-2
Zhan, W.-R., Huang, J., Zeng, P.-M., Tian, W.-Y., & Luo, Z. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab044 · Cited by 14
Haj, A. K., Hasan, H., & Raife, T. J. (2022) · Biomolecules · doi:10.3390/biom13010046 · Cited by 12
Impacts of SARS-CoV-2 on diabetes mellitus: A pre and post pandemic evaluation
Nabi, A. N., Ebihara, A., & Shekhar, H. U. (2023) · World Journal of Virology · doi:10.5501/wjv.v12.i3.151 · Cited by 15
Freitas, R. S., Roque, C. R., Matos, G. A., Belayev, L., de Azevedo, O. G. R., Alvarez-Leite, J. I., Guerrant, R. L., & Oriá, R. B. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab063 · Cited by 13
Vasile, M.-C., Arbune, A.-A., Lupăşteanu, G., Vlase, C.-M., Popovici, G.-C., & Arbune, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184210 · Cited by 13
Hubáček, J. (2021) · Physiological Research · doi:10.33549/physiolres.934730 · Cited by 12
The relationship of early- and late-onset Alzheimer’s disease genes with COVID-19
Şirin, S., Dolanbay, S. N., & Aslım, B. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02499-0 · Cited by 13
Nascimento, J. C. R., Pereira, L. C., Rêgo, J. M. D. C., Dias, R. P., Silva, P. G. B., Cândido-Sobrinho, S. A., Coelho, G., Brasil, I. R. C., de Oliveira-Filho, E. F., Owen, J. S., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i11.1064 · Cited by 12
Crook, H., Ramírez, A., Hosseini, A. A., Vavougios, G. D., Lehmann, C., Bruchfeld, J., Schneider, A., d’Avossa, G., Re, V. L., Salmoiraghi, A., et al. (2023) · Brain Connectivity · doi:10.1089/brain.2022.0058 · Cited by 12
Resolving heterogeneity in Alzheimer's disease based on individualized structural covariance network
Zheng, C., Zhao, W. D., Yang, Z., Tang, D., Feng, M., & Guo, S. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110873 · Cited by 13
Metadata
- Authors
- Kuo, C.-L., Pilling, L. C., Atkins, J. L., Masoli, J. A. H., Delgado, J., Kuchel, G. A., & Melzer, D.
- Affiliations
- UConn Health (US)
- University of Exeter (GB)
- Corresponding author
- Melzer, David
- ORCID
- Venue
- The Journals of Gerontology: Series A
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-26
- Volume
- 75
- Issue
- 11
- Pages
- 2231-2232
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- PMC
- PMC7314139
- OpenAlex
- W3031869734
- Cited by
- 388
- References
- 13
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 32 · 2023: 59 · 2022: 88 · 2021: 117 · 2020: 69
- FWCI
- 10.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journals of Gerontology Series A (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute on Aging (R21AG060018)
- UK Medical Research Council (MR/S009892/1)
- National Institute for Health Research (DRF-2014-07-177)
- Department of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- APOE ε4, COVID-19 severity, Alzheimer's disease risk, dementia, delirium, rs429358, rs7412, genetic susceptibility, older adults, UK Biobank, community-based cohort, SARS-CoV-2, European ancestry, comorbidities, mortality risk, hospitalization risk
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Aged, England, Female, Homozygote, Humans, Male, Pneumonia, Viral, Severity of Illness Index, Survival Analysis, Biological Specimen Banks, Coronavirus Infections, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Apolipoprotein E4, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
